Investment to expand manufacturing and global medicine supply capacity — resonating with the Make in India agenda Eli Lilly and Company today announced plans to invest more than $1 Billion over the next several years into new contract manufacturing in India, expanding patients’ access to innovative
ICMR validates indigenous innovations that drastically cut testing time and cost, accelerating India’s goal to eliminate tuberculosis by 2025In a major leap toward India’s mission to eliminate tuberculosis (TB), the Indian Council of Medical Research (ICMR) has validated two new Made-in-India diagnostic tests developed by
Investment to expand manufacturing and global medicine supply capacity — resonating with the Make in India agendaEli Lilly and Company today announced plans to invest more than $1 Billion over the next several years into new contract manufacturing in India, expanding patients’ access to innovative
With this addition, Fortis’ Delhi-NCR network grows to approx.2,000 beds, enabling expanded reach and stronger synergiesFortis Healthcare Limited today announced that its wholly owned subsidiary, International Hospital Limited (IHL), has entered into a 15-year lease agreement with RR Lifesciences Limited for a ~200-bed fully operational
OneSource Specialty Pharma Limited today announced the appointment of three new non-executive independent directors to its Board — Dr. Claudio Albrecht, Ms. Debarati Sen and Mr. Vijay Karwal—effective February 27, 2025. The directors bring decades of leadership experience and expertise in Pharma, Business Strategy, Transformation,
Suven Pharmaceuticals Ltd. has officially announced the appointment of Vivek Sharma as the new Executive Chairman, effective September 20, 2024. This transition comes as Vaidheesh Annaswamy steps down from the Board to take on the role of Vice-Chair of Suven’s Advisory Council, marking a significant
JV Ventures, an investment management firm with a focus on value-added infrastructure, today announced the launch of The Medical Centre (TMC). TMC is a holistic real estate solution that will create the best-in-class healthcare facility by bringing together convenient end-to-end medical services and integrated wellness
Eris Lifesciences Ltd., a leading Indian branded formulations company, today announced the expansion of its Sterile Injectables footprint through the acquisition of 51% equity stake in Swiss Parenterals Ltd. for a consideration of INR 637.50 crore. This deal also marks the entry of Eris into
Continues to build capacity for long-term growth; employee base crosses 12,000 ElxsiansTata Elxsi (BSE: 500408 | NSE: TATAELXSI), amongst the world’s leading providers of design led technology services, announced its first quarter results for the period ending 30th June 2023.Highlights of the Quarter Ended June
Zydus Lifesciences Limited (formerly known as Cadila Healthcare Limited) has received final approval from the United States Food and Drug Administration (USFDA) to market Micafungin for Injection, 50 mg/vial and 100 mg/vial, single-dose vials (USRLD: Mycamine®).Micafungin for Injection is indicated to treat variety of fungal infections. It
